CCO Expert Recap

Lung Cancer

Source: CCO Independent Conference Coverage of the 2008 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Lung Cancer

Program Director: Ramaswamy Govindan, MD

Faculty:

Ramaswamy Govindan, MD

CME CREDIT INFORMATION

Release Date: 08/15/08

Expiration Date: 08/14/09

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.5 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss recent clinical trial results regarding the use of monoclonal antibodies in the treatment of advanced non-small-cell lung cancer
Describe results from recent clinical trials of combinations of cytotoxic chemotherapies in the setting of lung cancer
Discuss novel therapies in the treatment of non-small-cell lung cancer
Recall results of recent clinical trials evaluating maintenance or early chemotherapy in approaches in patients undergoing therapy for non-small-cell lung cancer

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.